help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farsetti, A.
Right arrow Articles by Pontecorvi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farsetti, A.
Right arrow Articles by Pontecorvi, A.
Endocrinology Vol. 139, No. 11 4581-4589
Copyright © 1998 by The Endocrine Society


ARTICLES

Orphan Receptor Hepatocyte Nuclear Factor-4 Antagonizes Estrogen Receptor {alpha}-Mediated Induction of Human Coagulation Factor XII Gene1

A. Farsetti, F. Moretti, M. Narducci, S. Misiti, S. Nanni, M. Andreoli, A. Sacchi and A. Pontecorvi

Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute (A.F., F.M., M.N., S.M., S.N., A.S., A.P.); the Institute of Experimental Medicine, National Research Council/Second Chair of Endocrinology, University of Rome La Sapienza (A.F., F.M., S.M., M.A.); and the Institute of Medical Pathology, Catholic University (A.P.), Rome, Italy

Address all correspondence and requests for reprints to: Alfredo Pontecorvi, M.D., Catholic University and Molecular Oncogenesis Laboratory, Regina Elena Cancer Institute, Via delle Messi d’Oro 156, 00158 Rome, Italy.

Factor XII (FXII) is a liver-specific zymogen involved in the regulation of hemostasis, particularly in the activation of fibrinolysis. Transcription of the FXII gene is stimulated by estrogens through specific interaction of the estrogen receptor {alpha} (ER{alpha}) with an estrogen response element present on FXII promoter. Interestingly, the magnitude of ER{alpha} induction in liver HepG2 cells is much lower than in NIH3T3 fibroblasts, suggesting that cell-specific factors may modulate ER{alpha}-dependent trans-activation. Comparative footprinting analysis of FXII promoter (from nucleotides -181 to +49) in liver vs. non-liver cell environments allowed identification of four deoxyribonuclease I-protected sites only in the presence of HepG2 nuclear extracts. Computerized homology search identified sites III and IV as consensus binding sequences for the liver-enriched transcription factor hepatocyte nuclear factor-4 (HNF-4), formerly an orphan receptor belonging to the superfamily of steroid/thyroid hormone nuclear receptors. In transient transfection assays in NIH3T3 cells, HNF-4 significantly inhibited (70%) estrogen induction of FXII promoter while not affecting basal promoter activity. Conversely, HNF-4 did not inhibit estrogen inducibility of FXII promoter in HepG2 cells due to the high endogenous levels of HNF-4 protein. In gel shift assays, HNF-4, either present in HepG2 nuclear extracts or generated by in vitro transcription/translation, specifically bound FXII promoter. This interaction is strictly required in eliciting the antagonistic effect because in NIH3T3 cells, selective mutations of sites III and IV abrogated HNF-4 inhibitory properties. In the liver-specific environment, the same mutant construct exhibited higher estrogen-dependent inducibility compared with native promoter. Rescue of estrogen responsiveness was also achieved using a dominant negative HNF-4, which counteracted endogenous HNF-4 activity. In conclusion, our findings address a direct role for HNF-4 in modulating estrogen-dependent transcription of the FXII gene promoter.




This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
M. Marino, F. Acconcia, and A. Trentalance
Biphasic Estradiol-induced AKT Phosphorylation Is Modulated by PTEN via MAP Kinase in HepG2 Cells
Mol. Biol. Cell, June 1, 2003; 14(6): 2583 - 2591.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Marino, F. Acconcia, F. Bresciani, A. Weisz, and A. Trentalance
Distinct Nongenomic Signal Transduction Pathways Controlled by 17beta -Estradiol Regulate DNA Synthesis and Cyclin D1 Gene Transcription in HepG2 Cells
Mol. Biol. Cell, October 1, 2002; 13(10): 3720 - 3729.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
R. Di Bitondo, A. J. Hall, I. R. Peake, L. Iacoviello, and P. R. Winship
Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region
Hum. Mol. Genet., April 1, 2002; 11(7): 723 - 731.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Guo, C. Q. Cai, and P. C. Kuo
Hepatocyte Nuclear Factor-4alpha Mediates Redox Sensitivity of Inducible Nitric-oxide Synthase Gene Transcription
J. Biol. Chem., February 8, 2002; 277(7): 5054 - 5060.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Farsetti, M. Narducci, F. Moretti, S. Nanni, R. Mantovani, A. Sacchi, and A. Pontecorvi
Inhibition of ER{alpha}-Mediated Trans-Activation of Human Coagulation Factor XII Gene by Heteromeric Transcription Factor NF-Y
Endocrinology, August 1, 2001; 142(8): 3380 - 3388.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1998 by The Endocrine Society